Energy metabolism alteration and anticancer treatment: study of a troglitazone derivative in triple-negative breast cancer cells

Claire Muller (1) , Stéphanie Grandemange (1) , Jerome Kluza (2) , Frédéric Bost (3) , Eline Piquard (4) , Elia de Fays (1) , Michel Boisbrun (4) , Stéphane Flament (1) , Sabine Mazerbourg (1)

1 CRAN - Centre de Recherche en Automatique de Nancy
2 JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837
3 Signalisation moléculaire et obésité
4 L2CM - Laboratoire Lorrain de Chimie Moléculaire

Domaines: Cancer; Biologie cellulaire

Claire Muller, Stéphanie Grandemange, Jerome Kluza, Frédéric Bost, Eline Piquard, et al.. Energy metabolism alteration and anticancer treatment: study of a troglitazone derivative in triple-negative breast cancer cells. Cancer and Metabolism 2018, Jun 2018, Cambridge, United Kingdom. ⟨hal-01946195⟩